Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Bioanalysis
|
April 14, 2016
Challenges and opportunities for translating medical microdevices: insights from the programmable bio-nano-chip
Michael P McRae, Glennon Simmons, John T McDevitt
European Journal of Internal Medicine
|
December 5, 2024
Measuring the risk of clinical adverse events (RISK ACE) by quantifying liver function: A patient-centric model
John Kittelson, Michael P McRae, Gregory T Everson
Translational Gastroenterology and Hepatology
|
February 12, 2026
When should I repeat the endoscopy in my patient with compensated cirrhosis, whom I just scoped and who had no or small varices?
Joanne C Imperial, Michael P McRae, Gregory T Everson
Accounts of Chemical Research
|
July 7, 2016
Programmable Bio-nanochip Platform: A Point-of-Care Biosensor System with the Capacity To Learn
Michael P McRae, Glennon Simmons, Jorge Wong, et al.
Clinical and Translational Science
|
April 1, 2024
Within-individual reproducibility of a dual sample oral cholate challenge test (DuO) and simplified versions of the HepQuant SHUNT test
Michael P McRae, John Kittelson, Steve M Helmke, et al.
Basic & Clinical Pharmacology & Toxicology
|
January 15, 2024
Advances in noninvasive measurement of liver function and physiology: The HepQuant DuO test
Michael P McRae, John Kittelson, Steve M Helmke, et al.
Journal of Clinical Medicine
|
January 28, 2026
Utilization of the Disease Severity Index (DSI) from the HepQuant DuO Test Enhances Clinical Decision Making in Compensated Advanced Chronic Liver Disease
Kerry Whitaker, Joanne C Imperial, Michael P McRae, et al.
Journal of Biosensors & Bioelectronics
|
March 29, 2019
Programmable bio-nano-chip system: a flexible diagnostic platform that learns
John T McDevitt, Michael P McRae, Glennon W Simmons, et al.
Plos One
|
November 22, 2024
Cost-effectiveness of an oral cholate challenge test for the management of patients at risk for large esophageal varices
Shailesh Chavan, Michael P McRae, Kelly R Pitts, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 10, 2022
Compartmental model describing the physiological basis for the HepQuant SHUNT test
Michael P McRae, Steve M Helmke, James R Burton, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Bioanalysis
|
April 14, 2016
Challenges and opportunities for translating medical microdevices: insights from the programmable bio-nano-chip
Michael P McRae, Glennon Simmons, John T McDevitt
European Journal of Internal Medicine
|
December 5, 2024
Measuring the risk of clinical adverse events (RISK ACE) by quantifying liver function: A patient-centric model
John Kittelson, Michael P McRae, Gregory T Everson
Translational Gastroenterology and Hepatology
|
February 12, 2026
When should I repeat the endoscopy in my patient with compensated cirrhosis, whom I just scoped and who had no or small varices?
Joanne C Imperial, Michael P McRae, Gregory T Everson
Accounts of Chemical Research
|
July 7, 2016
Programmable Bio-nanochip Platform: A Point-of-Care Biosensor System with the Capacity To Learn
Michael P McRae, Glennon Simmons, Jorge Wong, et al.
Clinical and Translational Science
|
April 1, 2024
Within-individual reproducibility of a dual sample oral cholate challenge test (DuO) and simplified versions of the HepQuant SHUNT test
Michael P McRae, John Kittelson, Steve M Helmke, et al.
Basic & Clinical Pharmacology & Toxicology
|
January 15, 2024
Advances in noninvasive measurement of liver function and physiology: The HepQuant DuO test
Michael P McRae, John Kittelson, Steve M Helmke, et al.
Journal of Clinical Medicine
|
January 28, 2026
Utilization of the Disease Severity Index (DSI) from the HepQuant DuO Test Enhances Clinical Decision Making in Compensated Advanced Chronic Liver Disease
Kerry Whitaker, Joanne C Imperial, Michael P McRae, et al.
Journal of Biosensors & Bioelectronics
|
March 29, 2019
Programmable bio-nano-chip system: a flexible diagnostic platform that learns
John T McDevitt, Michael P McRae, Glennon W Simmons, et al.
Plos One
|
November 22, 2024
Cost-effectiveness of an oral cholate challenge test for the management of patients at risk for large esophageal varices
Shailesh Chavan, Michael P McRae, Kelly R Pitts, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 10, 2022
Compartmental model describing the physiological basis for the HepQuant SHUNT test
Michael P McRae, Steve M Helmke, James R Burton, et al.
Page
of 5